Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 7 - You Need To See This

S&P Futures Slip on U.S. Government Shutdown, ADP Jobs Report in Focus

December S&P 500 E-Mini futures (ESZ25) are trending down -0.56% this morning as sentiment took a hit after the U.S. government shut down for the first time in seven years.

Pfizer agrees to lower prescription drug costs for Medicaid

Pfizer agrees to lower prescription drug costs for Medicaid

Under the deal, New York-based Pfizer will charge most-favoured-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations.

TrumpRx: Trump and Pfizer Announce Landmark Deal to Slash US Drug Prices by Up to 85%

TrumpRx: Trump and Pfizer Announce Landmark Deal to Slash US Drug Prices by Up to 85%

TrumpRx will slash US drug prices by up to 85% under a new deal with Pfizer, bringing costs in line with other nations and boosting US investment.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

After badmouthing Tylenol, Trump makes deal with their rival company Pfizer

Weird how one happens before the other.

We Got This Covered

Trump news at a glance: Shutdown a chance to ‘get rid of a lot of things we didn’t want’, says president

Senate Democrats voted down a Republican bill to keep funding the government, putting it on a near certain path to a shutdown. Key US politics stories from 30 September 2025

The Guardian - US

Stocks Settle Higher as Drug Makers and Chip Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.28%. December E-mini S&P futures (ESZ25 ) rose +0.39%, and December E-mini Nasdaq futures...

Trump Announces Pfizer Deal He Says Will Lower Certain Drug Prices

The Trump administration on Tuesday announced a deal granting Pfizer a three-year reprieve on planned tariffs as the pharmaceutical giant vowed to voluntarily lower the prices of unspecified drugs for US purchase.

International Business Times

inkl

Read news from The Economist, FT, and more,
with one subscription

Pfizer Becomes First Drugmaker To Join Trump's Price Cut Push

On Tuesday, Pfizer Inc. (NYSE:PFE) announced a historic agreement with the Trump Administration to ensure U.S. patients pay lower prices for their prescription medicines.

Trump Seals Explosive Pfizer Deal To Cut Drug Prices With New TrumpRx Platform

Trump Seals Explosive Pfizer Deal To Cut Drug Prices With New TrumpRx Platform

Donald Trump has struck a headline-grabbing deal with Pfizer to slash US drug prices, launching a TrumpRx platform that bypasses intermediaries and raises major questions over enforcement and patient impact.

International Business Times UK

Pfizer agrees to offer discounted drugs through new federal website, Trump announces

Pfizer agrees to offer discounted drugs through new federal website, Trump announces

President also said that company would offer medications to Medicaid at ‘most favored nation’ pricing

The Guardian - US

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with President Donald Trump's administration

The Independent UK

Pfizer Shares Are Trading Higher Tuesday: What's Going On?

Pfizer Shares Are Trading Higher Tuesday: What's Going On?

Pfizer, Inc. (NYSE:PFE) shares are trading higher on Tuesday after The Washington Post reported that President Donald Trump will announce a drug-pricing deal with the company.

Pfizer sued in US over contraceptive that women say caused brain tumours

Pfizer sued in US over contraceptive that women say caused brain tumours

US class action lawsuit alleges company failed to warn about risks of using contraceptive injection Depo-Provera

The Guardian - UK

Pfizer is Locking in New Growth Through a New Acquisition

Pfizer is Locking in New Growth Through a New Acquisition

Pfizer is undergoing a new acquisition, exposing it to the weight loss market and additional revenue growth potential, which isn't priced in yet.

Get all your
news in one place.

100's of premium titles.
One news app.

Pfizer Faces Court Over Depo-Provera Brain Tumor Claims

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that could determine whether affected women can pursue their cases in court.

Mercosur deal: Von der Leyen being probed for auto-deleting Macron's text

A text message sent by Emmanuel Macron to Ursula von der Leyen is at the centre of an investigation by the European Ombudsman.

The Independent UK

Asian shares trade mixed after US stocks set more records

Asian shares are trading mixed in the absence of key market-driving news in the region, after a seemingly relentless rally continued on Wall Street

International Business Times UK

Metsera Stock Rockets After Pfizer's $7.3b — Should You Still Invest?

Metsera stock has soared after Pfizer announced a $7.3 billion acquisition, sparking investor buzz. Analysts are now weighing whether the biotech rally has more room to run or if buyers should stay cautious.

Get all your
news in one place.

100's of premium titles.
One news app.

Pfizer eyes obesity drug market as it seals $4.9bn deal for Metsera

Pharma giant Pfizer is betting on obesity treatments as it looks for new markets following the success of its COVID-19 vaccine.

Pfizer Tries To Revitalize Obesity Portfolio With $5 Billion Matsera Deal

Pfizer Inc. (NYSE:PFE) on Monday agreed to acquire Metsera, Inc. (NASDAQ:MTSR) to accelerate the next generation of medicines for obesity and cardiometabolic diseases.

The Independent UK

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera

Pfizer is doubling down on obesity treatments by spending $4.9 billion on the development-stage drugmaker Metsera

Why the Recovery in Pfizer Stock Could Be Bigger Than Investors Expect

Pfizer is quietly laying the foundation for a new era of sustainable growth.

Pfizer Reportedly Nears Metsera Acquisition Deal: PFE Stock Climbs In Monday Pre-Market

Pfizer Inc. (NYSE:PFE) stock climbed 1.54% in Monday pre-market amid reports that the company on the verge of acquiring Metsera Inc. (NASDAQ:MTSR), a developer of anti-obesity drugs.

The 5 Best Dividend Stocks to Buy for Steady Income in 2025

Here are five “set-and-forget” dividend stocks.

Blue Chip Stocks With Fat Dividends: Smart Buy Or Value Trap?

Investors love blue-chip stocks that pay fat dividends, but high yield alone doesn’t guarantee a safe income stream.

1 … 6 7 8 9

People

198,335 stories

Emmanuel Macron

Ursula von der Leyen

Stacie Dusetzina

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the White House

The New York Times

Harvard University

the Trump Administration

The Washington Post

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Government Shutdown

Prescription Drug

Places

390,187 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play